Literature DB >> 12595587

Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease.

Takeshi Yoshioka1, Takaji Matsutani, Tomoko Toyosaki-Maeda, Hiroyuki Suzuki, Sigeru Uemura, Ryuji Suzuki, Michio Koike, Yorio Hinuma.   

Abstract

We previously reported that the frequency of TCRBV2 and TCRBV6S5-bearing T-cells was high in patients in the acute phase of Kawasaki disease (KD) and that streptococcal pyrogenic exotoxin C (SPE-C) was a potent stimulator of these TCRBV-bearing T-cells. To further elucidate the pathogenesis of KD, we examined the T-cell receptor (TCR) repertoire, human leukocyte antigen (HLA)-DRB1 genotype, and antibody responses to recombinant(r) SPE-C in patients with KD. We also performed in vitro stimulation with rSPE-A and rSPE-C of peripheral blood mononuclear cells from healthy donors and characterized the reacting T-cells. The percentage of T-cells bearing TCRBV2 and TCRBV6S5 was high in patients in the acute stage of KD. rSPE-C stimulation of PBMC from healthy donors induced expansion of TCRBV2 and TCRBV6S5-bearing T-cells. Furthermore, serum levels of anti-SPEC antibodies, which did not display antimitogenic activity, were higher in patients with acute KD than in age-matched controls. The frequencies of the DRB1*04051, 0406, and 0901 were high, whereas that of the DRB1*1101 was low among patients with KD as compared with the healthy adults.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595587     DOI: 10.1203/01.PDR.0000049668.54870.50

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

1.  Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.

Authors:  K Matsubara; T Fukaya; K Miwa; N Shibayama; H Nigami; H Harigaya; H Nozaki; T Hirata; K Baba; T Suzuki; A Ishiguro
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

Review 2.  Sex Differences in Pediatric Rheumatology.

Authors:  Marco Cattalini; Martina Soliani; Maria Costanza Caparello; Rolando Cimaz
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

3.  The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms?

Authors:  A R Porcalla; C A Sable; K M Patel; G R Martin; N Singh
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

4.  Comprehensive analysis and characterization of the TCR alpha chain sequences in the common marmoset.

Authors:  Yoshiki Fujii; Takaji Matsutani; Kazutaka Kitaura; Satsuki Suzuki; Tsunetoshi Itoh; Tomohiko Takasaki; Ryuji Suzuki; Ichiro Kurane
Journal:  Immunogenetics       Date:  2010-04-20       Impact factor: 2.846

5.  Impact of T-cell receptor Vbeta haplotypes on the development of dermatitis in DS-Nh mice: synergistic production of interleukin-13 caused by staphylococcal enterotoxin C and peptide glycans from Staphylococcus aureus.

Authors:  Takeshi Yoshioka; Kinichi Imura; Ichiro Hikita; Tsutomu Hirasawa; Tsuneaki Sakata; Takaji Matsutani; Tatsuya Horikawa; Akinori Arimura
Journal:  Immunology       Date:  2007-02-20       Impact factor: 7.397

6.  Bacterial superantigens and T cell receptor beta-chain-bearing T cells in the immunopathogenesis of ulcerative colitis.

Authors:  N Shiobara; Y Suzuki; H Aoki; A Gotoh; Y Fujii; Y Hamada; S Suzuki; N Fukui; I Kurane; T Itoh; R Suzuki
Journal:  Clin Exp Immunol       Date:  2007-07-05       Impact factor: 4.330

Review 7.  Pathogenetic determinants in Kawasaki disease: the haematological point of view.

Authors:  Domenico Del Principe; Donatella Pietraforte; Lucrezia Gambardella; Alessandra Marchesi; Isabella Tarissi de Jacobis; Alberto Villani; Walter Malorni; Elisabetta Straface
Journal:  J Cell Mol Med       Date:  2017-01-07       Impact factor: 5.310

Review 8.  Current perspectives on Kawasaki disease.

Authors:  Monesha Gupta-Malhotra; P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.